05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
On October 18, 2019, the US Court of Appeals for the Federal Circuit affirmed the Armed Services Boa...
Read More >
The Internal Revenue Service (IRS) has established a process that requires all retirement plan spons...
Read More >
On August 20, 2019, the Bernalillo County, New Mexico Commissioners enacted the "Employee Wellness A...
Read More >
Two documents were prepared by the Arkansas Department of Energy and Environment – Division of Envi...
Read More >
Generally, for a tax qualified retirement plan to be adopted, the plan document must be signed and d...
Read More >
A New Jersey lawmaker recently took a big step towards creating a system of benefits for gig economy...
Read More >